The latest wave of digital transformation to hit clinical trials is here, and sponsors are looking to AI, clinical data analytics, and cloud computing to bring innovation to the way clinical trials are designed, planned, and executed.
OM033577
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
AI, Analytics, and Cloud Computing Are Transforming Clinical Trials
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Federated and Swarm Learning in Healthcare
Report / 16 Jun 2023 / Andrew Brosnan
Federated and swarm learning are distributed learning frameworks for machine learning training sets. These frameworks enable AI models to be trained on distributed datasets across organizational silos or across disparate organizations to provide more comprehensive datasets versus localized and siloed datasets. This helps to provide more robust AI models and address bias inherent in localized healthcare datasets.
UPGRADE
Artificial Intelligence Software Market Forecasts – 1H24 Data
Data / 03 Jun 2024 / Neil Dunay
Analysis of the market opportunity for AI software in 2022–28. Includes market sizing, segmentation, and forecasts for generative (GenAI) and predictive AI across more than 150 use cases, 20 industries, eight regions, and four workloads.
UPGRADE
Quantum Computing in the Life Sciences – 2023
Report / 20 Sep 2023 / Andrew Brosnan
This report analyzes why and how the life sciences industry is adopting quantum computing (QC) and how QC’s current state maps to the needs of the pharmaceutical industry, particularly within the drug discovery process.
UPGRADE
2024 Trends to Watch: AI in Healthcare
Report / 10 Jan 2024 / Andrew Brosnan
This report provides key 2024 predictions and trends for AI healthcare and life sciences in 2024 with an impact assessment rating for each one, and strategic recommendations for selected stakeholders.
UPGRADE
Healthcare AI Maturity and AI Budget Survey Analysis – 2023
Survey / 29 Jun 2023 / Andrew Brosnan
This report discusses the current state of AI market adoption and insights into key success factors for operationalizing AI in the healthcare sector based on surveying 52 enterprises from every global region, all company sizes by revenue.
UPGRADE
2023 Trends To Watch: AI in Healthcare
Report / 14 Dec 2022 / Andrew Brosnan
AI adoption in healthcare is set to increase rapidly over the next few years. Proof-of-concept pilots, early deployments in production, and their use during the pandemic have bolstered confidence in AI’s value to the industry.
UPGRADE
An error occured. Please try again later
You are now following this Analyst
You unfollowed this Analyst
Become A Client
Find out more about our full suite of products and solutions.
Become A ClientYou must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Thank you
Our expert analysts will review your question and the Ask an Analyst team will get back to you. We aim to respond within 24 hours, but we’re often quicker.
Ask an Analyst
Our team of experts are here to answer your questions. From advice on market trends to a query on research point, and everything in between, we want to hear from you.
Ask an analyst is available as part of a subscription. If you'd like access, contact us today.